Northwest Oncology & Hematology

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Lung cancer2 trials
• Pancreatic cancer2 trials
• Endometrial cancer1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Melanoma1 trial

Phase

• Phase 22 trials

Status

• Active, not recruiting1 trial
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Freenome Holdings Inc.1 trial
• Partner Therapeutics, Inc.1 trial
• Tempus AI1 trial

Running trials

• Active, not recruiting

  A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

  NCT02912949· Phase 2· Partner Therapeutics, Inc.· Source

Closed trials

• Terminated

  Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

  NCT05169437· Phase 2· Tempus AI· Source

• Completed

  Prevention of Colorectal Cancer Through Multiomics Blood Testing

  NCT04369053· Freenome Holdings Inc.· Source